Search research articles
Contact Us
Filters
Showing results (431-440 of 455) with videos related to
Page
of 46
Sort By:
Gynecologic Oncology
|
January 11, 2026
Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/ SHAPE trial
Se Ik Kim, Jae-Weon Kim, Janice S Kwon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2019
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
Josep M Del Campo, Ursula A Matulonis, Susanne Malander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2016
Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE)
Christian Kurzeder, Isabel Bover, Frederik Marmé, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 21, 2015
Pazopanib Maintenance Therapy in East Asian Women With Advanced Epithelial Ovarian Cancer: Results From AGO-OVAR16 and an East Asian Study
Jae-Weon Kim, Sven Mahner, Ling-Ying Wu, et al.
American Journal of Obstetrics and Gynecology
|
January 16, 2021
p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group
Linn Woelber, Katharina Prieske, Christine Eulenburg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium
Nicole Concin, Ioana Braicu, Pierre Combe, et al.
Breast Cancer Research : BCR
|
October 24, 2020
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial
Amelie de Gregorio, Lothar Häberle, Peter A Fasching, et al.
The New England Journal of Medicine
|
February 28, 2019
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms
Philipp Harter, Jalid Sehouli, Domenica Lorusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2017
Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes
Stefan Kommoss, Boris Winterhoff, Ann L Oberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 30, 2016
Corrigendum to "Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group" [Eur J Cancer 49 (2013) 1905-1914]
Andreas du Bois, Nina Ewald-Riegler, Nikolaus de Gregorio, et al.
Page
of 46
Search research articles
Search
Showing results (431-440 of 455) with videos related to
Sort By:
Page
of 46
Gynecologic Oncology
|
January 11, 2026
Comparative outcomes of simple versus radical hysterectomy in patients with and without very low-risk early-stage cervical cancer: An exploratory analysis from the Gynecologic Cancer Intergroup/Canadian Cancer Trials Group CX.5/ SHAPE trial
Se Ik Kim, Jae-Weon Kim, Janice S Kwon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 8, 2019
Niraparib Maintenance Therapy in Patients With Recurrent Ovarian Cancer After a Partial Response to the Last Platinum-Based Chemotherapy in the ENGOT-OV16/NOVA Trial
Josep M Del Campo, Ursula A Matulonis, Susanne Malander, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 9, 2016
Double-Blind, Placebo-Controlled, Randomized Phase III Trial Evaluating Pertuzumab Combined With Chemotherapy for Low Tumor Human Epidermal Growth Factor Receptor 3 mRNA-Expressing Platinum-Resistant Ovarian Cancer (PENELOPE)
Christian Kurzeder, Isabel Bover, Frederik Marmé, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
November 21, 2015
Pazopanib Maintenance Therapy in East Asian Women With Advanced Epithelial Ovarian Cancer: Results From AGO-OVAR16 and an East Asian Study
Jae-Weon Kim, Sven Mahner, Ling-Ying Wu, et al.
American Journal of Obstetrics and Gynecology
|
January 16, 2021
p53 and p16 expression profiles in vulvar cancer: a translational analysis by the Arbeitsgemeinschaft Gynäkologische Onkologie Chemo and Radiotherapy in Epithelial Vulvar Cancer study group
Linn Woelber, Katharina Prieske, Christine Eulenburg, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 28, 2025
GANNET53 Part II: A European Phase I/II Trial of the HSP90 Inhibitor Ganetespib in High-Grade Platinum-Resistant Ovarian Cancer-A Study of the GANNET53 Consortium
Nicole Concin, Ioana Braicu, Pierre Combe, et al.
Breast Cancer Research : BCR
|
October 24, 2020
Gemcitabine as adjuvant chemotherapy in patients with high-risk early breast cancer-results from the randomized phase III SUCCESS-A trial
Amelie de Gregorio, Lothar Häberle, Peter A Fasching, et al.
The New England Journal of Medicine
|
February 28, 2019
A Randomized Trial of Lymphadenectomy in Patients with Advanced Ovarian Neoplasms
Philipp Harter, Jalid Sehouli, Domenica Lorusso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 5, 2017
Bevacizumab May Differentially Improve Ovarian Cancer Outcome in Patients with Proliferative and Mesenchymal Molecular Subtypes
Stefan Kommoss, Boris Winterhoff, Ann L Oberg, et al.
European Journal of Cancer (Oxford, England : 1990)
|
July 30, 2016
Corrigendum to "Borderline tumours of the ovary: A cohort study of the Arbeitsgemeinschaft Gynäkologische Onkologie AGO Study Group" [Eur J Cancer 49 (2013) 1905-1914]
Andreas du Bois, Nina Ewald-Riegler, Nikolaus de Gregorio, et al.
Page
of 46